GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aroa Biosurgery ARX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.51

-4.72%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

7 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 4Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 0.84

Low
0.80
Average
0.84
Median
0.84
High
0.89

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029
RevenueNZD 150.1mNZD 172.3mNZD 157.8m
Revenue, highestNZD 152.5mNZD 178.0mNZD 162.5m
Revenue, lowestNZD 147.8mNZD 165.4mNZD 153.8m
Earnings per share0.020.040.06
Earnings per share, highest0.020.060.08
Earnings per share, lowest0.010.020.04
Analysts333

Earnings against forecasts

Earnings per share by fiscal quarter

Q1 2026Q3 2025Q3 2024Q1 2024Q3 2023
Forecast0.000.01-0.01-0.00-0.01
Reported0.02-0.00-0.01-0.01-0.02
Difference+297.6%-131.4%-37.5%-292.9%-22.1%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 63.4% a year over 10 years. Return on equity 6.3%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.